200 filings
Page 2 of 10
424B5
xf7 ma70f8n
27 Aug 19
Prospectus supplement for primary offering
9:32pm
8-K
tmtk2u4h6pu0akve30
9 Aug 19
Sophiris Bio Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
8:10am
8-K
54qgb0 5kea2f4dqhq
28 Jun 19
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
rt84 6fpkno9z2r0tune
7 Jun 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:38pm
8-K
3op43zce26123uj8
9 May 19
Sophiris Bio Reports First Quarter 2019 Financial Results
4:06pm
DEFA14A
obyhy7fku4zqtpcb
30 Apr 19
Additional proxy soliciting materials
4:07pm
8-K
t825u xif2vb
13 Mar 19
Sophiris Bio Reports Fourth Quarter 2018 and Year-end Financial Results and Recent Corporate Highlights
4:07pm
8-K
8qmbvw03ot qsg
3 Jan 19
Departure of Directors or Certain Officers
4:18pm
CT ORDER
i80qyysxu3ad8918vi
21 Dec 18
Confidential treatment order
12:00am
8-K
ae00r rnuh6m88x
17 Dec 18
Sophiris Bio Provides Updates on Phase 2b Localized Prostate Cancer Trial
8:05am
424B5
ecv5n18vtsmks5
7 Dec 18
Prospectus supplement for primary offering
5:23pm
8-K
vwdn0y27
7 Dec 18
Entry into a Material Definitive Agreement
5:21pm
8-K
bjggfswix9 4x2fritl
13 Nov 18
Sophiris Bio Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights
4:06pm
8-K
iz5 wa25g
30 Aug 18
Sophiris Bio Updates on Phase 2b Localized Prostate Cancer Trial
12:00am